Functional Precision
Medicine Solution

For Cancer Treatment

Optimai logo TM transparent White

Optim.AI™ is a Combinatorial drug sensitivity platform that predicts the most effective treatment options for each individual cancer patient using limited tumor tissue

KYAN Technologies, a pioneering leader in functional precision medicine for oncology, is revolutionizing cancer care with cutting-edge technology developed by its distinguished scientific founders at University of California Los Angeles and National University Singapore.
UCLA
  • Optim.AI™
  • Personalized Cancer Solution
  • Small Data AI
  • Functional Precision Medicine
  • Biopharma
  • Optim.AI™
  • Personalized Cancer Solution
  • Small Data AI
  • Functional Precision Medicine
  • Biopharma

Our Technology

Optim.AI™ is a revolutionary technology that efficiently solves large & complex search spaces

Optim.ai technology

Our Solutions

Functional Precision Medicine for Patients & Drug Development

Clinical Decision Support

Delivering truly personalized medicine solution to empower oncologists in tailoring patient-specific treatments.

Biopharma R&D Services

The only platform that efficiently solves large and complex search spaces to accelerate drug development.

Clinically Validated

0

Clinical Studies

0 +

Publications

Our Investors & Collaborators